News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Aggarwal Gaurav
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/13/2023 |
4
| Aggarwal Gaurav (Director) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Converted 3,470,152 shares
@ $0
Converted 8,077 preferred shares
@ $1000, valued at
$8.1M
Converted 13,429,000 preferred shares
@ $0
Converted 12,802,388 options to buy
@ $0.539, valued at
$6.9M
Converted 11,638,534 options to buy
@ $0.5929, valued at
$6.9M
Converted 18,621,655 options to buy
@ $0.7411, valued at
$13.8M
|
|
| 03/09/2023 |
4
| Aggarwal Gaurav (Director) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Granted 8,077 convertible preferred
@ $1000, valued at
$8.1M
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2022 |
4
| Aggarwal Gaurav (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Bought 800,000 shares
@ $27, valued at
$21.6M
|
|
| 01/28/2022 |
4
| Aggarwal Gaurav (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Exercised (in-or-at-the-money) 1,455,384 options to buy
@ $13.2, valued at
$19.2M
|
|
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2020 |
4
| Aggarwal Gaurav (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 6,874 options to buy
@ $13.98, valued at
$96.1k
|
|
| 01/31/2020 |
4
| Aggarwal Gaurav (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Converted 1,455,576 shares
@ $0
Converted 19,213 options to buy
@ $0 |
|
| 12/03/2019 |
4
| Aggarwal Gaurav (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 60,000 options to buy
@ $0.3467, valued at
$20.8k
|
|
| 01/19/2016 |
4
| Aggarwal Gaurav (Chief Business Officer) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $2.15, valued at
$21.5k
|
|
| 01/07/2016 |
4
| Aggarwal Gaurav (Chief Business Officer) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Granted 147,975 options to buy
@ $2.98, valued at
$441k
Granted 49,325 options to buy
@ $2.98, valued at
$147k
|
|
| 06/22/2015 |
4
| Aggarwal Gaurav (Chief Business Officer) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $3.76, valued at
$282k
|
|
| 05/06/2015 |
4
| Aggarwal Gaurav (Chief Business Officer) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Bought 7,500 shares
@ $3.62, valued at
$27.2k
|
|
| 06/13/2014 |
4
| Aggarwal Gaurav (Chief Business Officer) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $7.84, valued at
$196k
|
|
| 05/02/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/02/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|